Diadema Partners LP Sc Pharmaceuticals Inc. Transaction History
Diadema Partners LP
- $391 Billion
- Q3 2025
A detailed history of Diadema Partners LP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Diadema Partners LP holds 462,000 shares of SCPH stock, worth $2.62 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
462,000
Previous 217,623
112.29%
Holding current value
$2.62 Million
Previous $829 Million
215.93%
% of portfolio
0.67%
Previous 0.25%
Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
116Shares Held
38.3MCall Options Held
835KPut Options Held
173K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.13MShares$12.1 Million0.05% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...